Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Refugees | 7 | 2024 | 612 | 2.720 |
Why?
|
| Forensic Medicine | 2 | 2024 | 64 | 1.580 |
Why?
|
| Prisons | 2 | 2020 | 178 | 0.740 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2020 | 50 | 0.680 |
Why?
|
| Interviews as Topic | 1 | 2024 | 2740 | 0.540 |
Why?
|
| Mother-Child Relations | 1 | 2020 | 501 | 0.530 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 549 | 0.430 |
Why?
|
| Infectious Disease Transmission, Vertical | 3 | 2015 | 1360 | 0.400 |
Why?
|
| Child Abuse | 1 | 2020 | 1096 | 0.370 |
Why?
|
| Central America | 2 | 2021 | 69 | 0.370 |
Why?
|
| Psychotherapy | 1 | 2020 | 1656 | 0.370 |
Why?
|
| Curriculum | 1 | 2024 | 3776 | 0.360 |
Why?
|
| Anti-HIV Agents | 7 | 2015 | 4571 | 0.350 |
Why?
|
| Lamivudine | 3 | 2001 | 367 | 0.350 |
Why?
|
| Zidovudine | 3 | 2001 | 625 | 0.340 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2015 | 2185 | 0.290 |
Why?
|
| Physical Examination | 2 | 2024 | 1262 | 0.260 |
Why?
|
| Violence | 2 | 2023 | 938 | 0.260 |
Why?
|
| Pediatrics | 1 | 2020 | 3624 | 0.240 |
Why?
|
| Primary Health Care | 1 | 2020 | 4748 | 0.220 |
Why?
|
| United Nations | 1 | 2023 | 151 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3118 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 4641 | 0.200 |
Why?
|
| Nelfinavir | 1 | 2001 | 68 | 0.190 |
Why?
|
| Zambia | 4 | 2015 | 273 | 0.180 |
Why?
|
| Guatemala | 1 | 2021 | 161 | 0.180 |
Why?
|
| Human Rights | 1 | 2023 | 312 | 0.180 |
Why?
|
| HIV Infections | 6 | 2015 | 17575 | 0.180 |
Why?
|
| Acetophenones | 1 | 1999 | 52 | 0.160 |
Why?
|
| Spouse Abuse | 1 | 2020 | 182 | 0.160 |
Why?
|
| Needs Assessment | 1 | 2024 | 1142 | 0.150 |
Why?
|
| Patient Care | 1 | 2023 | 629 | 0.150 |
Why?
|
| Acetamides | 1 | 1999 | 260 | 0.140 |
Why?
|
| Emigration and Immigration | 1 | 2020 | 406 | 0.140 |
Why?
|
| School Health Services | 1 | 2020 | 389 | 0.140 |
Why?
|
| Medical History Taking | 1 | 2020 | 776 | 0.130 |
Why?
|
| Child Welfare | 1 | 2020 | 523 | 0.130 |
Why?
|
| Public Policy | 1 | 2020 | 551 | 0.130 |
Why?
|
| Drug Therapy, Combination | 4 | 2014 | 6318 | 0.110 |
Why?
|
| United States | 5 | 2024 | 73150 | 0.110 |
Why?
|
| Lost to Follow-Up | 1 | 2013 | 123 | 0.100 |
Why?
|
| Resilience, Psychological | 1 | 2020 | 805 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2013 | 2596 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2020 | 6034 | 0.080 |
Why?
|
| Rural Population | 3 | 2015 | 2318 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2020 | 1731 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2024 | 4848 | 0.080 |
Why?
|
| Risk | 1 | 2020 | 9636 | 0.070 |
Why?
|
| Humans | 15 | 2024 | 768393 | 0.070 |
Why?
|
| Prevalence | 1 | 2021 | 15872 | 0.060 |
Why?
|
| Child | 3 | 2024 | 80891 | 0.060 |
Why?
|
| RNA, Viral | 2 | 2001 | 2866 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 4411 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8753 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2015 | 26411 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2014 | 3464 | 0.040 |
Why?
|
| Nausea | 1 | 2001 | 682 | 0.040 |
Why?
|
| HIV Protease Inhibitors | 1 | 2000 | 432 | 0.040 |
Why?
|
| Pregnancy | 3 | 2015 | 30200 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 42650 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2024 | 1407 | 0.030 |
Why?
|
| Adolescent | 3 | 2020 | 89184 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2001 | 12456 | 0.030 |
Why?
|
| Maternal-Child Health Centers | 1 | 2015 | 42 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2001 | 1445 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 74962 | 0.030 |
Why?
|
| Diarrhea | 1 | 2001 | 1320 | 0.030 |
Why?
|
| Transportation | 1 | 2015 | 217 | 0.030 |
Why?
|
| Female | 7 | 2020 | 397089 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2013 | 41795 | 0.030 |
Why?
|
| HIV-1 | 2 | 2001 | 6963 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4859 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 4039 | 0.030 |
Why?
|
| Young Adult | 3 | 2015 | 60049 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2000 | 1903 | 0.020 |
Why?
|
| Health Policy | 1 | 2024 | 2698 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2015 | 8731 | 0.020 |
Why?
|
| Adult | 6 | 2015 | 223640 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2001 | 2693 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 54920 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2015 | 1159 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 5512 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2014 | 1364 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 1133 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2014 | 2505 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 26375 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9682 | 0.010 |
Why?
|
| HIV Protease | 1 | 2000 | 98 | 0.010 |
Why?
|
| Male | 5 | 2014 | 364902 | 0.010 |
Why?
|
| Survival Rate | 1 | 2014 | 12870 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 830 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39407 | 0.010 |
Why?
|
| Viral Load | 1 | 2000 | 3398 | 0.010 |
Why?
|
| Genotype | 1 | 2000 | 13042 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 223491 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_